©2025 Stanford Medicine
Mild Depression 2 Week Observational Study
Not Recruiting
Trial ID: NCT00285831
Purpose
The purpose of this study is to assess whether the dysphoric-like depressive characteristics observed in people with epilepsy are unique to this patient population in comparison to three control groups: Mild Depression (enrolled at Stanford University), Migraine Headaches (enrolled at Long Island Jewish Medical Center), and Multiple Sclerosis (enrolled at Rush University Medical Center).
Official Title
Dysphoric-like Disorder of Epilepsy, Is it Unique?
Stanford Investigator(s)
John Barry, MD
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology - Adult), Emeritus
Eligibility
Inclusion Criteria::
" Male or female 18 years of age or older. " Presence of a Depressive disorder that presents as a dysthymic or minor depressive disorder and whose score on the Beck Depression Inventory (BDI) range between 11 and 20. Patients with major depression will be excluded.
" Is currently on stable doses of medications i.e., no change in treatment in the previous 30 days.
" Achieves a satisfactory score on the WRAT3 (standard score is \> 69). " Is capable of completing the self-reporting questionnaires. " Is willing and able to provide written informed consent and comply with the study protocol\
Exclusion Criteria:" Presence of a clinically significant comorbidity of an unstable or progressive nature (e.g., psychosis, delirium) that could, in the opinion of the investigator, prevent completion of the questionnaires or warrant immediate medical intervention.
" Participation in an investigational trial within the past 30 days. " Inability to communicate well with site study personnel, e.g. inability to read or understand English, poor mental development or impaired brain function.
" Patients with a clinical picture that meets criterion of major depression.
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Jessica Hawkins
6507238323